Published in Lancet on August 03, 1985
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A (2007) 1.35
A mouse model of familial porphyria cutanea tarda. Proc Natl Acad Sci U S A (2001) 1.11
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci (2002) 1.06
Environmental chemical exposures and disturbances of heme synthesis. Environ Health Perspect (1997) 0.98
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid. Biochem J (1988) 0.89
Genetic variation of iron-induced uroporphyria in mice. Biochem J (1993) 0.87
Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism. Biochem J (1986) 0.83
CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda. Mol Med (2010) 0.82
HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol (2007) 0.81
Hepatoerythropoietic porphyria precipitated by viral hepatitis. Gut (1993) 0.81
An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report. World J Gastroenterol (2007) 0.76
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda. Clin Exp Immunol (2001) 0.75
Heterogeneity of familial porphyria cutanea tarda. J Med Genet (1988) 0.75
Porphyria cutanea tarda due to ferrous gluconate. CMAJ (1990) 0.75
Economic stress, coercive family process, and developmental problems of adolescents. Child Dev (1994) 5.45
A family process model of economic hardship and adjustment of early adolescent boys. Child Dev (1992) 4.32
Pubertal transition, stressful life events, and the emergence of gender differences in adolescent depressive symptoms. Dev Psychol (2001) 3.79
Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun (1981) 3.16
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
Competence in early adult romantic relationships: a developmental perspective on family influences. J Pers Soc Psychol (2000) 2.87
Macrocyclic intermediates in the biosynthesis of porphyrins. Philos Trans R Soc Lond B Biol Sci (1976) 2.73
Are religious grandparents more involved grandparents? J Gerontol B Psychol Sci Soc Sci (1999) 2.36
Molecular epidemiology of erythropoietic protoporphyria in the U.K. Br J Dermatol (2010) 2.15
Couple resilience to economic pressure. J Pers Soc Psychol (1999) 2.09
Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev (1996) 2.08
Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTs1 receptor. J Cell Biol (1996) 2.01
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology (1995) 1.88
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Expression of pertussis toxin correlates with pathogenesis in Bordetella species. J Infect Dis (1989) 1.82
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg (2000) 1.78
Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol (1982) 1.77
Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol (2006) 1.77
Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet (1997) 1.69
Pathways of economic influence on adolescent adjustment. Am J Community Psychol (1999) 1.69
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol (1995) 1.68
Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis. Infect Immun (1979) 1.65
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
A radiochemical method for the measurement of coproporphyrinogen oxidase and the utilization of substrates other than coproporphyrinogen III by the enzyme from rat liver. Biochem J (1978) 1.58
ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science (1988) 1.57
Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol (2001) 1.56
Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther (2012) 1.55
The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol (1985) 1.53
Continuities and consequences of interactional styles across the life course. J Pers (1989) 1.52
Linking family hardship to children's lives. Child Dev (1985) 1.52
Pertussis but not cholera toxin inhibits the stimulated increase in actin association with the cytoskeleton in rabbit neutrophils: role of the "G proteins" in stimulus-response coupling. Biochem Biophys Res Commun (1985) 1.51
ACP Best Practice No 165: front line tests for the investigation of suspected porphyria. J Clin Pathol (2001) 1.50
Parent-adolescent reciprocity in negative affect and its relation to early adult social development. Dev Psychol (2001) 1.49
The efficacy of a serum screening service for neural-tube defects: the South Wales experience. Lancet (1983) 1.49
Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology (1985) 1.47
A simple in vitro method for studies on chemotaxis. Proc Soc Exp Biol Med (1974) 1.46
Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians (1999) 1.46
Crystallization of pertussigen from Bordetella pertussis. Infect Immun (1981) 1.45
Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med (1978) 1.39
Inflammatory cloacogenic polyp: three cases and literature review. Am J Gastroenterol (1994) 1.38
A MspI polymorphism for the human porphobilinogen deaminase gene. Nucleic Acids Res (1987) 1.37
Porphyrin metabolism in porphyria cutanea tarda. Semin Hematol (1977) 1.35
Can we afford screening for neural tube defects? The South Wales experience. Br Med J (Clin Res Ed) (1985) 1.34
Hemagglutinin antibody response of normal and Aleutian disease-affected mink to keyhole limpet hemocyanin. J Immunol (1970) 1.29
A 50-year prospective study of the psychological sequelae of World War II combat. Am J Psychiatry (1995) 1.29
Detection of subunits of pertussis toxin in Tn5-induced Bordetella mutants deficient in toxin biological activity. Infect Immun (1987) 1.28
The porphyrias: a review. J Clin Pathol (1972) 1.28
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg (1998) 1.28
Evidence that the coproporphyrinogen oxidase activity of rat liver is situated in the intermembrane space of mitochondria. Biochem J (1978) 1.26
Husband and wife differences in response to undesirable life events. J Health Soc Behav (1993) 1.24
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials. Anal Biochem (1986) 1.24
Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces. J Clin Pathol (1975) 1.24
The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat. Clin Sci Mol Med (1976) 1.24
The intergenerational transmission of health-risk behaviors: adolescent lifestyles and gender moderating effects. J Health Soc Behav (1999) 1.23
Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol (1984) 1.20
Investigation of the subcellular location of the tetrapyrrole-biosynthesis enzyme coproporphyrinogen oxidase in higher plants. Biochem J (1993) 1.18
Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J Exp Med (1983) 1.18
DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria. Lancet (1987) 1.17
Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch Biochem Biophys (2000) 1.17
New reference allelic ladders to improve allelic designation in a multiplex STR system. Int J Legal Med (1998) 1.16
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration. Am J Gastroenterol (2000) 1.16
Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infect Immun (1978) 1.16
A highly discriminating octoplex short tandem repeat polymerase chain reaction system suitable for human individual identification. Electrophoresis (1995) 1.16
Appearance and education in marriage mobility. Am Sociol Rev (1969) 1.16
Family history and the life course. J Fam Hist (1977) 1.15
Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem (1998) 1.13
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? Lancet (1981) 1.12
Pertussis toxin as a probe of neutrophil activation. Fed Proc (1986) 1.12
Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1979) 1.11
Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver. Biochem J (1983) 1.11
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase. Clin Sci (Lond) (1980) 1.09
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology (2000) 1.09
Worklives and longevity: insights from a life course perspective. J Health Soc Behav (1993) 1.09
The primary enzyme defect in hereditary coproporphyria. Lancet (1976) 1.08
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology (1987) 1.05
Isocoproporphyrin: nuclear-magnetic-resonance-and mass-spectral methods for the determination of porphyrin structure. Biochem J (1973) 1.04
Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology (1998) 1.04
Centrobin regulates the assembly of functional mitotic spindles. Oncogene (2010) 1.04
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology (2000) 1.04
Nutritional supplementation in chronic liver disease: an analytical review. Hepatology (1994) 1.03
Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448. Biochem J (1984) 1.03
A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol (2011) 1.01
Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene. Biochem Biophys Res Commun (1982) 1.00
Increased histamine sensitivity in mice after administration of endotoxins. Infect Immun (1977) 0.99
Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects. Virology (1998) 0.99
Intergenerational continuity of parental rejection and depressed affect. J Pers Soc Psychol (1992) 0.99
Factors determining the sequence of oxidative decarboxylation of the 2- and 4-propionate substituents of coproporphyrinogen III by coproporphyrinogen oxidase in rat liver. Biochem J (1978) 0.99
Short tandem repeat typing of bodies from a mass disaster: high success rate and characteristic amplification patterns in highly degraded samples. Biotechniques (1995) 0.98
Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology (1998) 0.98
The metabolism of porphyrins of the isocoproporphyrin series. Enzyme (1974) 0.98
Decreased activity of uroporphyrinogen decarboxylase caused by 2,4,5,3',4'-pentabromobiphenyl in chick embryo hepatocyte cultures. Difference in activity in intact or homogenized cells. FEBS Lett (1983) 0.98
Acute intermittent porphyria caused by a C----T mutation that produces a stop codon in the porphobilinogen deaminase gene. Hum Genet (1990) 0.97
Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin). Infect Immun (1987) 0.97
Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda. Lancet (1983) 0.96
Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction. Enzyme (1982) 0.96
Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. J Allergy Clin Immunol (1975) 0.95